Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 5, 2015 9:15 AM 1 min read

Morgan Stanley Cuts Bloomin' Brands On 'Thesis Creep'

by Jim Swanson Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

  • Bloomin' Brands Inc (NASDAQ: BLMN) shares have declined 32.07 percent year-to-date, touching a low of 16.97 on October 30.
  • Morgan Stanley’s John Glass has downgraded the rating on the company from Overweight to Equal-weight, while lowering the price target from $25 to $19.
  • The downgrade is based on “thesis creep,” with the key assumptions underlying appear to have eroded over the past few quarters.

Analyst John Glass explained that although the current valuation was the lowest among peers, near-term comps are likely to decline, labor-related margin pressure has been rising and there is “tail risk from Brazil.”

“While our initial recommendation on this name was predicated on accelerating traffic gains vs its peers, unit growth, store remodels/relocations and margin improvement, many of those have become less impactful drivers than we'd initially hoped,” Glass went on to say.

Bloomin’ Brands is expected to continue to see weak same store sales, not only in Q4 but also in 1H16, as the company laps the elevated sales gains from 2014.

According to the Morgan Stanley report, “Typically there is a high correlation between comp deceleration and earnings multiples in restaurants.”

Although Glass had expected the company to generate positive gap to industry traffic at Outback, the gap has turned slightly negative in the previous quarter, driven by increased competition, “less effective” promotions and “the brand pivoting back to higher check, less discounted, steak-centric offers.”

“Based on tougher comparisons, we expect BLMN comps to be challenged over the next three quarters,” Glass added.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorDowngradesPrice TargetAnalyst RatingsJohn GlassMorgan Stanley
BLMN Logo
BLMNBloomin Brands Inc
$6.94-0.30%
Overview
BLMN Logo
BLMNBloomin Brands Inc
$6.94-0.30%
Overview
Comments
Loading...